semaglutide weight regain after stopping GLP-1 loss effects treatment Woman shares journey of weight

Common Side Effects of GLP-1 Medications Serious but Rare Side Effects Who Should Use GLP-1 Medications With Caution

Wadden T et al

For people currently on tirzepatide who find the weekly wearing-off effect unmanageable even after dose optimization, switching to semaglutide is sometimes discussed as an option

[PMC free article: PMC11397063] [PubMed: 39275201] Substance Identification Substance Name Semaglutide CAS Registry Number 910463-68-2 Drug Class Breast Feeding Milk, Human Hypoglycemic Agents Incretins Glucagon-Like Peptide-1 Agonists GLP-1 Agonists Disclaimer: Information presented in this database is not meant as a substitute for professional judgment

Meto's pre-treatment lab panel is purpose-built for GLP-1 initiation, covering all metabolically relevant biomarkers in a single blood draw

These treatments are designed to work synergistically, promoting holistic wellness